Header
Header
Article

New patent for Abbvie Inc drug MAVYRET – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Abbvie Inc drug MAVYRET


Annual Drug Patent Expirations for MAVYRET

Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are nine patents protecting this drug.

MAVYRET drug price trends.

The generic ingredient in MAVYRET is glecaprevir; pibrentasvir. One supplier is listed for this compound. Additional details are available on the glecaprevir; pibrentasvir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Abbvie Inc drug MAVYRET



Source link

Back to top button